Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Dexamethasone/Remdesivir/Rituximab

Lack of efficacy, off-label use and progressive lung disease

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Raia SA, et al. Hidden Dangers: A Case of Progressive Lung Disease in an Immunocompromised Patient, Found to Have Persistent COVID Positivity on Bronchoscopy. American Journal of Respiratory and Critical Care Medicine 207: A1464, May 2023. Available from: URL: https://dx.doi.org/10.1164/ajrccm-conference.2023.A37 [abstract] Raia SA, et al. Hidden Dangers: A Case of Progressive Lung Disease in an Immunocompromised Patient, Found to Have Persistent COVID Positivity on Bronchoscopy. American Journal of Respiratory and Critical Care Medicine 207: A1464, May 2023. Available from: URL: https://dx.doi.org/10.1164/ajrccm-conference.2023.A37 [abstract]
Metadaten
Titel
Dexamethasone/Remdesivir/Rituximab
Lack of efficacy, off-label use and progressive lung disease
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-54455-1

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Oxcarbazepine

Case report

Cefepime

Case report

Multiple drugs

Case report

Nivolumab

Case report

Purified-talc